Janssen Pharmaceuticals Settlement Aids Lompoc Remediation
- Document date
- Apr 18, 2026
The 30-second brief
Through an opioid settlement with Janssen Pharmaceuticals, Inc., Lompoc receives dedicated funding for opioid remediation. These payments contribute to the City’s long-term $1.4 million settlement pool.
Janssen Pharmaceuticals Inc holds this financial services contract with City of Lompoc. Its other public contracts on record include work for City of Gulf Breeze and Town of Mooresville.
Term as filed: Payments over approximately 18 years (combined with other 2021–2025 settlements).
See who decides the next one before it's bid.
Get pre-RFPs freeFree account · 30-second setup · No credit card
Contract details
- Contract type
- Financial Services
- Document date
- April 18, 2026
- Term
- Payments over approximately 18 years (combined with other 2021–2025 settlements)
- Agency
- City of Lompoc
- Source document
- City of Lompoc Council Agenda Item April 2026 (Agenda)
Janssen Pharmaceuticals Inc's other public contracts
More City of Lompoc contracts
Questions about this contract
Who was awarded the financial services contract by City of Lompoc?
Janssen Pharmaceuticals Inc was awarded this financial services contract by City of Lompoc, as recorded on April 18, 2026.
What type of contract is this?
This is a Financial Services contract, documented as a agenda record.
Where was this contract approved?
This contract appears in City of Lompoc Council Agenda Item April 2026 (Agenda), dated April 18, 2026 from City of Lompoc. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does Janssen Pharmaceuticals Inc hold?
Janssen Pharmaceuticals Inc may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is City of Lompoc currently buying?
Explore City of Lompoc's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.